DOT extends comment period on oral drug testing
March 21, 2022
The U.S. Department of Transportation is giving the public more time to comment on its proposal to include oral fluid in its drug testing programs.
After receiving feedback from stakeholders suggesting that March 30 wasn’t enough time to prepare comments, the U.S. DOT elected to extend the deadline until April 29. The notice for the extension of the comment period is scheduled to publish in the Federal Register on Tuesday, March 22.
“DOT stakeholders have expressed concern that this closing date does not provide sufficient time to coordinate with their respective members to develop comments to the notice of proposed rulemaking and/or to submit comments to the docket,” the notice stated.
Oral fluid drug testing proposal
On Feb. 28, the Department of Transportation published a notice of proposed rulemaking to amend the industry’s drug testing procedures.
The proposal follows the Department of Health and Human Services’ 2019 rule that allowed federal executive branch agencies to use oral fluid specimens as part of the drug testing. Although the rule went into effect on Jan. 1, 2020, each agency is required to go through its own rulemaking process. The notice of proposed rulemaking marked the beginning of that process for the Department of Transportation.
“This will give employers a choice that will help combat employee cheating on urine drug tests and provide a more economical, less intrusive means of achieving the safety goals of the program,” the notice stated. “The proposal includes other provisions to update the department’s regulation and to harmonize, as needed, with the new mandatory guidelines for federal workplace drug testing programs using oral fluid established by the U.S. Department of Health and Human Services.”
How to comment
Under the extension, the public will now have 60 days to respond to the proposal instead of 30.
To date, more than 160 comments have been filed to the docket. LL